Latest S-1 registration statements

Connexa Sports Technologies has filed an amendment to its Form S-1 registration statement, covering the offer and sale of up to 2,200,000 shares of common stock by selling stockholders.

Thunder Power Holdings updates its registration statement for the potential sale of up to 17,616,408 shares of common stock by selling securityholders.

Venu Holding Corporation updates its IPO registration statement and secures an extension for a land purchase agreement in El Paso, Texas, signaling continued progress in its expansion plans.

Glucotrack aims to raise up to $30 million by offering common stock, pre-funded warrants, and common stock purchase warrants.

Apimeds Pharmaceuticals US, Inc. is seeking to go public to fund clinical trials for its bee venom-based therapy, Apitox, targeting osteoarthritis and multiple sclerosis symptoms.

Mullen Automotive is registering for resale up to 30 million shares of its common stock by selling stockholders, derived from convertible notes and warrants.

Cloudastructure, Inc. files an amendment to its S-1 registration statement for a direct listing of its Class A common stock on the Nasdaq Capital Market.

Natures Miracle Holding Inc. has filed a registration statement to increase the maximum aggregate offering price of its securities by $1,000,000.

Virpax Pharmaceuticals is offering up to 6,883,260 shares of common stock and pre-funded warrants in a best efforts offering to raise capital for clinical trials, working capital, and general corporate purposes.

GSR III Acquisition Corp., a blank check company, has filed an amendment to its registration statement for a $200 million initial public offering.

Drugs Made In America Acquisition Corp., a blank check company targeting the pharmaceutical industry, has filed Amendment No. 3 to its Form S-1 registration statement for a $200 million initial public offering.

Thunder Power Holdings, Inc. obtains a $350,060 promissory note from Wellen Sham with a 10% interest rate, maturing in 365 days.

Solera Corp., a leading global provider of SaaS solutions for the vehicle lifecycle ecosystem, has filed for an IPO to raise capital for debt repayment and general corporate purposes.

Stryve Foods is undertaking a public offering to sell shares of Class A Common Stock, pre-funded warrants, and common warrants to raise capital for working capital and general corporate purposes.

DarkPulse is set to acquire key assets from the liquidated Optilan (UK) Limited while simultaneously filing an S-1 amendment to register shares for a $30 million equity financing agreement with GHS Investments LLC.

Artius II Acquisition Inc., a blank check company, has filed an S-1 registration statement for a $200 million IPO, aiming to pursue a business combination with a technology-focused company.

Alpha Cognition USA Inc. enters into an employment agreement with Henry Du as VP, Finance and Accounting, while the company prepares for a public offering.

Sonnet BioTherapeutics plans to offer common stock and warrants to purchase common stock, aiming to raise capital for research and development, working capital, and debt repayment.

Natures Miracle Holding Inc. plans to offer up to 25,746,653 units, each with common stock and warrants, and register 3,317,400 shares for resale by selling stockholders.

Wellgistics Health, a holding company focused on pharmaceuticals and healthcare services, has filed an S-1/A form with the SEC to register shares of its common stock for an initial public offering, with plans to list on the Nasdaq Capital Market under the symbol 'WGRX'.

Health In Tech, Inc. has filed Amendment No. 4 to its Form S-1 registration statement for a proposed IPO of 2,300,000 shares of Class A Common Stock and the potential resale of 1,969,585 shares by a selling shareholder.

A SPAC III Acquisition Corp. is seeking to raise $55 million through an IPO to pursue a business combination in the ESG and material technology sectors.

Global Crossing Airlines aims to register the resale of up to 23.3 million shares by selling stockholders, including shares from warrants and Class A non-voting stock conversions.

Eterna Therapeutics has filed a registration statement for the potential resale of up to 49,870,566 shares of its common stock by selling stockholders.

1606 Corp. has filed a registration statement for the resale of up to 29,876,884 shares of its common stock by the selling stockholder, GHS Investments LLC, following an equity financing agreement.

Plum Acquisition Corp. IV updates its registration statement for a proposed $200 million initial public offering, targeting a business combination in any sector.

Horizon Space Acquisition II Corp., a blank check company with ties to China, files an amendment to its S-1 registration statement for a proposed $60 million initial public offering.

Hyperscale Data, Inc. seeks to raise up to $37.5 million by offering 1,500,000 shares of its 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock through a resale registration statement.

Lixte Biotechnology Holdings is offering up to 1,895,734 units, each consisting of common stock or pre-funded warrants and common warrants, aiming to raise approximately $4 million for working capital and general corporate purposes, including advancing its cancer therapies.

Tenon Medical, Inc. files an amendment to its Form S-1 registration statement related to the resale of common stock and the exercise of warrants.